CareDx, Inc (NASDAQ:CDNA) Has Attractive Fundamentals

CareDx, Inc (NASDAQ:CDNA) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of CDNA, it is a company with strong financial health as well as a buoyant future outlook. In the following section, I expand a bit more on these key aspects. For those interested in digging a bit deeper into my commentary, read the full report on CareDx here.

Flawless balance sheet with high growth potential

CDNA is an attractive stock for growth-seeking investors, with an expected earnings growth of 87% in the upcoming year. Earnings growth is paired with an eye-catching top-line trajectory also doubling over the same period, which indicates a high-quality bottom-line expansion, as opposed to those driven by unsustainable cost-cutting activities. CDNA’s ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. This implies that CDNA manages its cash and cost levels well, which is a crucial insight into the health of the company. CDNA currently has no debt on its balance sheet. This implies that the company is running its operations purely on off equity funding. which is typically normal for a small-cap company. Therefore the company has plenty of headroom to grow, and the ability to raise debt should it need to in the future.

NasdaqGM:CDNA Past and Future Earnings, August 19th 2019
NasdaqGM:CDNA Past and Future Earnings, August 19th 2019

Next Steps:

For CareDx, there are three relevant aspects you should look at:

  1. Historical Performance: What has CDNA’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
  2. Valuation: What is CDNA worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether CDNA is currently mispriced by the market.
  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of CDNA? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.